Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

Share Price is delayed by 15 minutes
Get Live Data
0.105    0.00 (0.00%)
Bid:
0.10
Ask:
0.11
Spread: 0.01 (10.00%)
Market Cap: £1.55m
GUN Live PriceLast checked at - London Stock Exchange

Intraday Gunsynd Share Chart

Low6 Update

15 Feb 2021 07:00

RNS Number : 0268P
Gunsynd PLC
15 February 2021
 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

Low6 Update

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce that it has received a shareholder update from its investee company Low6 Limited ("Low6"), a UK based, influencer led, B2B pool betting platform for franchises around the world. Low6 offers a white-label pool betting platform for professional sports franchises.

 

In Q4 2020, Low6 closed a pre-IPO round, organised by Canaccord Genuity. As announced on 14 December 2020, Gunsynd subscribed for 6,667 ordinary shares at a price of £30 per share for a total consideration of £200,010.

 

Low6 advised in its shareholder update that it is proposing to extend the pre-IPO round to allow a very well-respected figure in the worldwide gaming industry to invest a significant sum in Low6 and join the Low6 advisory board from the IPO. Proceeds from the extended pre-IPO round will be deployed to build user growth on the various platforms.

 

Low6 stated in its shareholder update that it now has just short of 80,000 users. Over 80% of these users are "Gen Z" and Millennials, a target demographic of many gaming companies worldwide. Low6 stated that its new user Cost per Acquisition (CPA) is very low, below £25 per monthly active user across all partners.

 

Low6 advises that three new influencer partners, Arsenal Fan TV, The United Stand TV and True Geordie, have had an impact ahead of its expectations. In January 2021, Low6 launched UFC Picks mobile application in partnership with the Ultimate Fighting Championship ("UFC"), on time and on budget. The app for Rangers FC went live on the 11 February 2021. 

 

Low6's IPO plans to list on the Australian Securities Exchange ("ASX") are on track, with a listing targeted for the first half of 2021.

 

Peter Ruse, Gunsynd PLC Director, commented: "Gunsynd is very pleased to provide this update to our shareholders. The Low6 business has demonstrated strong monthly active user growth since our investment in December 2020, launching its pool betting software across a number of platforms within popular sporting codes. We believe the cost per acquisition of users to the Low6 platform is considerably lower than the industry average and proves the disruptive nature of this business. Furthermore, we are delighted to learn that the business has attracted what it believes to be a high calibre gaming investor to its shareholder register and advisory board."

 

About Low6 Limited

Low6 Limited a next generation sports betting platform. Further information can be found at https://low6.co.uk

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

 

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

The Directors of Gunsynd accept responsibility for this announcement.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris / Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCDKQBNDBKBKBD
Date   Source Headline
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising
12th Mar 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSDirectorate Change
2nd Feb 20102:30 pmRNSResult of AGM
7th Jan 20107:00 amRNSPreliminary results
12th Nov 20097:00 amRNSBusiness Update
12th Nov 20097:00 amRNSClinical results from Phase II cosmetic study
28th Apr 20097:00 amRNSHalf Yearly Report
14th Apr 20097:00 amRNSRe Contract
3rd Nov 20087:00 amRNSFinal Results
25th Sep 20087:00 amRNSChange of Adviser
29th Aug 20087:00 amRNSTotal Voting Rights
12th Aug 200811:58 amRNSHolding(s) in Company
6th Aug 20081:13 pmRNSResult of EGM & Director's In
15th Jul 20087:00 amRNSProposed fundraising
3rd Jul 20087:00 amRNSProctor & Gamble Agreement
24th Apr 20087:00 amRNSInterim Results
25th Feb 20087:00 amRNSPositive Trial Results
4th Feb 200810:51 amRNSHolding(s) in Company
21st Dec 20072:50 pmRNSOral Healthcare Agreement
15th Nov 20074:03 pmRNSAnnual Report and Accounts
18th Oct 20077:01 amRNSPreliminary Results
16th Aug 20077:00 amRNSPhase I Results
13th Jun 20077:01 amRNSPhase I Acne Trial Starts
8th May 20077:02 amRNSCRO Appointment
30th Apr 20079:00 amRNSTotal Voting Rights
25th Apr 200710:45 amRNSDirector/PDMR Shareholding
24th Apr 20074:12 pmRNSAdditional Listing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.